You can use fundamental analysis to find out if Chemours is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found thirty-six available fundamental indicators for Chemours Company which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Chemours fundamentals including its Shares Owned by Institutions, Price to Sales and the relationship between Shares Outstanding and Price to Earning . Given that Chemours has Number of Shares Shorted of 12.56 M, we suggest you validate Chemours Company prevailing market performance to make sure the company can sustain itself down the road. Use Chemours to enhance returns of your portfolios. The stock experiences very speculative upward sentiment. . Check odds of Chemours to be traded at $18.55 in 30 days.
Chemours Company Summary
Chemours competes with Albemarle, Cabot, Ecolab, and Element Solutions. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in USA and is traded on BATS Exchange. It employs 7000 people.
Chemours Return On Equity vs Number of Shares Shorted
Chemours Company is rated below average in return on equity category among related companies. It is rated fourth in number of shares shorted category among related companies making about 125,600,000,000 of Number of Shares Shorted per Return On Equity.
|Return On Equity ( % )|
|Number of Shares Shorted|
Chemours Systematic Risk
Chemours Thematic Clasifications
Chemours October 14, 2019 Opportunity Range